Martin Landray

Research interests

Publications

• Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02074-8

• Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

  medRxiv · 2021 · https://doi.org/10.1101/2021.02.11.21249258

• Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study

  ˜The œLancet. Gastroenterology & hepatology · 2021 · https://doi.org/10.1016/s2468-1253(21)00005-4

• Dexamethasone in Hospitalized Patients with Covid-19.

  DiRROS repository (University of Maribor) · 2020 · https://doi.org/10.17863/cam.57006

• Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

  JAMA · 2020 · https://doi.org/10.1001/jama.2020.17023

• Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

  medRxiv · 2020 · https://doi.org/10.1101/2020.06.22.20137273

• COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31356-8

• Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)32013-4

• The Magic of Randomization versus the Myth of Real-World Evidence

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmsb1901642

• Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

  The Lancet · 2019 · 10.1016/s0140-6736(18)31942-1

• 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

  Circulation · 2018 · https://doi.org/10.1161/circulationaha.117.033502

• Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

  European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy100

• A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury

  American Journal of Kidney Diseases · 2015 · https://doi.org/10.1053/j.ajkd.2015.02.337

• UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

  PLoS Medicine · 2015 · https://doi.org/10.1371/journal.pmed.1001779

• A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury

  American Journal of Kidney Diseases · 2015 · https://doi.org/10.1053/j.ajkd.2015.02.338

• Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

  Journal of the American Society of Nephrology · 2014 · https://doi.org/10.1681/asn.2013090965

• Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

  Journal of the American Society of Nephrology · 2014 · https://doi.org/10.1681/asn.2013090965

• HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

  European Heart Journal · 2013 · 10.1093/eurheartj/eht055

• HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

  European Heart Journal · 2013 · 10.1093/eurheartj/eht055

• HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

  European Heart Journal · 2013 · 10.1093/eurheartj/eht055

• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  The Lancet · 2011 · https://doi.org/10.1016/s0140-6736(11)60739-3

• Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study

  American Journal of Kidney Diseases · 2010 · https://doi.org/10.1053/j.ajkd.2010.07.016

• Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study

  American Journal of Kidney Diseases · 2004 · https://doi.org/10.1053/j.ajkd.2003.10.037

Current projects

No projects listed.